Nexsen Limited (ASX:NXN)
Australia · Delayed Price · Currency is AUD 0.1600
0.00 (0.00%)
At close: Nov 10, 2026
Nexsen Market Cap
Nexsen has a market cap or net worth of 32.03 million as of November 10, 2026. It is the 36,058th most valuable company in the world and the 912th biggest in Australia. Its market cap has decreased by 5.88% in one year.
Market Cap
32.03M
Enterprise Value
27.55M
Revenue
n/a
Global Rank
Country Rank
#912 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since October 14, 2025, Nexsen's market cap has decreased from 56.05M to 32.03M, a decrease of -42.86%. That is a compound annual growth rate of -40.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 32.03M | - |
| Dec 31, 2025 | 32.03M | -42.86% |
| Oct 14, 2025 | 56.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 59.57M |
| Entropy Neurodynamics | 47.37M |
| Avecho Biotechnology | 46.36M |
| Neurizon Therapeutics | 44.96M |
| Amplia Therapeutics | 42.60M |
| Immutep | 36.84M |
| Neurotech International | 30.71M |
| Botanix Pharmaceuticals | 24.86M |